Paracetamol Injection

    • Product Name: Paracetamol Injection
    • Chemical Name (IUPAC): N-(4-hydroxyphenyl)acetamide
    • CAS No.: 103-90-2
    • Chemical Formula: C8H9NO2
    • Form/Physical State: Liquid
    • Factroy Site: No. 777, Shengli West Road, Yuhui District, Bengbu City, Anhui Province, China
    • Price Inquiry: sales3@ascent-chem.com
    • Manufacturer: Anhui BBCA Group Co., Ltd
    • CONTACT NOW
    Specifications

    HS Code

    640901

    Generic Name Paracetamol
    Dosage Form Injection
    Route Of Administration Intravenous
    Strength 10 mg/mL
    Indications Pain relief, Fever reduction
    Mechanism Of Action Inhibits prostaglandin synthesis in CNS
    Onset Of Action Within 5-10 minutes
    Duration Of Action 4-6 hours
    Contraindications Severe hepatic impairment
    Common Side Effects Nausea, vomiting, hypotension
    Storage Temperature Below 25°C
    Packaging Glass vial or ampoule
    Prescription Status Prescription only
    Atc Code N02BE01

    As an accredited Paracetamol Injection factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Application of Paracetamol Injection

    Purity 99%: Paracetamol Injection with purity 99% is used in postoperative pain management, where it ensures rapid and consistent reduction of moderate to severe pain.

    pH 5.5–7.0: Paracetamol Injection with pH range 5.5–7.0 is used in emergency departments, where it minimizes venous irritation and promotes patient comfort during intravenous administration.

    Sterile formulation: Paracetamol Injection in sterile formulation is used in critical care units, where it reduces the risk of microbial contamination and ensures patient safety.

    Osmolarity 270–310 mOsm/L: Paracetamol Injection with osmolarity 270–310 mOsm/L is used in pediatric wards, where it prevents cellular damage and extravasation during infusion.

    Stability at 25°C: Paracetamol Injection stable at 25°C is used in ambulatory care settings, where it maintains efficacy and safety throughout standard storage and transport.

    Concentration 10 mg/mL: Paracetamol Injection at concentration 10 mg/mL is used in oncology supportive care, where it delivers precise dosing for effective antipyretic response without fluid overload.

    Endotoxin level <0.25 EU/mL: Paracetamol Injection with endotoxin level <0.25 EU/mL is used in immunocompromised patients, where it limits the risk of pyrogenic reactions post-administration.

    Low particulate matter: Paracetamol Injection with low particulate matter is used in neonatal intensive care, where it avoids vascular complications and ensures safe intravenous therapy.

    Amber glass ampoule packaging: Paracetamol Injection packaged in amber glass ampoules is used in hospital pharmacies, where it protects active ingredients from photodegradation and ensures long-term stability.

    Preservative-free: Paracetamol Injection in preservative-free form is used in allergy-prone individuals, where it eliminates adverse hypersensitivity reactions associated with preservatives.

    Packing & Storage
    Packing Paracetamol Injection packaging includes a sterile, clear glass vial containing 100 ml solution, labeled with dosage, batch number, and expiry date.
    Container Loading (20′ FCL) Container Loading (20′ FCL): Paracetamol Injection securely packed in cartons, palletized, and loaded for export; capacity: approximately 1,200–1,500 cartons.
    Shipping Paracetamol Injection is shipped in temperature-controlled packaging to maintain stability, typically between 15°C to 30°C. All containers are securely sealed and clearly labeled in compliance with pharmaceutical regulations. Shipments include safety documentation and are handled by licensed carriers to ensure product quality and safe delivery to healthcare facilities.
    Storage Paracetamol Injection should be stored below 25°C (77°F), protected from light and moisture. Keep it in its original packaging until use to prevent contamination. Do not freeze. Ensure the storage area is secure, away from incompatible substances, and inaccessible to unauthorized personnel or children. Always check expiration dates and discard any solution that appears discolored or contains particulate matter.
    Shelf Life Paracetamol Injection typically has a shelf life of 24 months when stored below 25°C, protected from light and freezing conditions.
    Free Quote

    Competitive Paracetamol Injection prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: sales3@ascent-chem.com

    Get Free Quote ofAnhui BBCA Group Co., Ltd

    Flexible payment, competitive price, premium service - Inquire now!

    More Introduction

    Paracetamol Injection: Experience and Understanding from the Manufacturing Floor

    Delivering Pain Relief Where It's Needed Most

    Every day, our production halls run with one goal above all: bring relief and safety to patients. Paracetamol injection, known in many places as acetaminophen injection, is one of the staples in our hospital-focused line. Oral formulations like tablets and syrup reach most homes and clinics, but the need for rapid, reliable action in medical emergencies shaped our work to perfect a true injectable solution.

    We’ve been part of the journey from raw material to finished sterile vial. Manufacturing this injectable form, we start with high-purity paracetamol, carefully sourced and rigorously tested before it enters the plant. Injections differ in many respects from their oral cousins. Our teams prepare concentrated paracetamol solutions, always under tight temperature and humidity controls that oral formulations simply do not require. The importance of particle size and consistency often goes unnoticed outside a plant, but those details determine both safety and speed of onset.

    Injections bring paracetamol directly into the bloodstream. That path means every microbe, every stray particle, risks a patient’s health. Our records go back decades, and the entire system moves under a strict culture of cleanliness. Filtration steps strip away undissolved particles, using pharmaceutical-grade filters, never cutting corners. Autoclaves and sterilization tunnels see constant servicing. Vials might seem simple, but each one faces visual inspection, leak testing, and batch reporting before we even consider packing.

    Why Paracetamol Injection Matters in Practice

    Oral paracetamol works well for mild pains and fevers, but not all patients can swallow pills. In post-surgical wards, intensive care, pediatric units, and trauma situations, doctors cannot wait the 30 to 45 minutes it takes a tablet to dissolve and reach full effect. Infusion and injection, by drawing paracetamol directly into circulation, help bring relief fast—typically within 5 to 10 minutes after administration. Experience at the hospital bedside tells us that treating severe headache, musculoskeletal pain, or fever in vulnerable patients often comes down to speed. Delays mean suffering, sometimes complications.

    The injectable option also sidesteps the gastrointestinal tract. For patients nauseated after surgery, vomiting, or unable to eat, oral delivery isn’t an option. Rectal suppositories exist, but their absorption varies and isn’t always practical. In contrast, injection eliminates those variables, helping doctors and nurses maintain control over dosing and timing. Each vial gives precise control: no guessing, less risk of overdose or underdose, even in children and elderly adults.

    We listen to caregivers when refining specifications. They tell us about handling: clear labeling, easy grip, and break-resistant glass reduce stress in emergencies. Nurses explain how a cloudy or colored injection raises doubts, so clarity of our solution remains a point of pride and a baseline test—no batches depart the plant until they pass these checks. After working shoulder-to-shoulder on hundreds of audit days, it’s clear: those on the ground notice the difference.

    Specifications Shaped by Experience

    Our standard paracetamol injection runs at 10 mg per mL concentration, with clinical use supporting this as the optimal blend of safety and effectiveness. Most common vial sizes sit at 2 mL and 5 mL, equating to 20 mg and 50 mg per vial, though we scale to 100 mL for infusion use as needed by hospitals. Our teams track every batch from incoming raw material through to finished vial, using in-line sensors and high-performance liquid chromatography. Stability remains our guiding star—injectables go into environments where time, temperature, and outcomes are under tight observational windows.

    The role of excipients—substances added for solubility and stability—can’t be ignored. We’ve tested a range over the years, but experience shows that minimal additions, “just enough but no more,” ensure patient safety. Our typical formula uses sterile water for injection alongside minimal stabilizers, mainly sodium hydroxide and hydrochloric acid to maintain physiological pH. Anything beyond that shows up in impurities or complicates compatibility with other injectable drugs, so we invest time and care in monitoring even tiny changes between batches.

    Manufacturing standards reflect international and local regulations, but for us, it’s more than paperwork. Engineers in the facility wear the responsibility: contamination risks, batch records, and environmental monitoring logs matter so much because outcomes matter even more. From regular swab tests on surfaces to annual recertification of our clean rooms, every step ties back to patients on the receiving end.

    Differences Between Paracetamol Injection and Other Formulations

    Tablets form the major share of paracetamol output worldwide. They cost less and reach more people, but the downside stays clear—slower action, possible gastrointestinal side effects, and limited use for some patients. Suppositories offer some flexibility but don’t have predictable absorption, varying with patient age and condition. Powders and suspensions help in pediatric dosing, but again, rely on a cooperative digestive system and a steady hand for dosing accuracy. We’ve seen how these differences play out, not just on paper but in daily hospital rounds and during crisis triages.

    Injectables also operate under stricter quality demands than oral forms. Where finished tablets might pass with minor blemishes or variations, a single cloudy vial or mislabeling in injectables means recall, investigation, and retraining. Each batch receives sterility and endotoxin testing—steps not required for non-sterile oral forms. This work means higher upfront cost and more scrupulous operator oversight, but the goal remains unchanged: unconditional trust from medical staff and peace of mind for patients.

    As manufacturers, we also track compatibility. Injectable paracetamol needs to work as a stand-alone IV push or as part of a multi-drug infusion. Interactions with other drugs—opioid co-administration, antibiotics, or electrolyte replacements—must show absence of precipitation or degradation. Our labs test for interactions under a range of temperatures and storage conditions, and only those products passing these stress tests move ahead to market. Every time a nurse adds paracetamol to a saline drip, all our silent work with beakers and chromatography pays off.

    Unlike tablets, which tolerate a broad range of shelf conditions, paracetamol injection demands a temperature-controlled supply chain. No cold chain slip can be allowed—product sits with wholesalers, pharmacies, ambulance kits, and finally at bedside. Each break in that chain risks degradation and less reliable pain control. Every year, we train and audit our partners to handle and store injectables with full traceability. Failures anywhere ripple out as real harm at the point of care, something those in chemical manufacturing understand down to their core.

    Meeting Challenges on the Ground

    New challenges come with global health events, raw material shortages, and evolving medical needs. During pandemic waves, we saw demand soar as many patients relied on paracetamol injection for fever management in critical care. At times when transport bottlenecks threatened our supply chain, the decision to keep larger buffer stocks of both raw material and finished vials paid off. Hospitals across regions wrote to us, sharing stories—not spreadsheets—of lives made easier by having fast-acting, safe injectable pain relief. Such stories validate every overtime shift and every closed-loop audit.

    Our plant engineers refine sterilization and filling methods with a focus on reducing human intervention. Automation allows us to trace every batch, every anomaly, so tracking and recall, if ever needed, happen within hours, not days. This vigilance means our partners in pharmacy, procurement, and logistics know their trust rests on decades of daily vigilance.

    Patients in oncology wards, neonatal ICUs, surgical units, and trauma centers all benefit from this injectable form. For newborns and children, low-volume vials made dosing manageable and minimized waste. In geriatric wards, the bypass of oral administration reduces aspiration risk and helps maintain dignity and safety. Emergency medical services—ambulances, field clinics, disaster relief—rely heavily on injectable formats due to unpredictable field conditions.

    Safety and Transparency at the Manufacturing Core

    Safety in injectable paracetamol starts long before the first bottle leaves the line. Every raw chemical faces identity, purity, and trace contamination tests. Our teams document every step. How we manage solvent recovery, glass vial quality, and staff hygiene becomes the backbone of our program. We publish annual summaries of quality incidents, actions taken, and ongoing improvements—not as a marketing move, but as a mark of respect to those who trust us.

    Doctors and pharmacists often reach out regarding compatibility or side effect questions. We offer direct access to batch records, impurity profiles, and real-time temperature data from our warehouses and distribution partners. Experience taught us that transparency earns long-term relationships; hiding problems damages not just business, but public health.

    We remain in constant dialogue with healthcare providers. Reports of rare side effects, notifications of patient oddities—even potential counterfeit detection—flow into our quality group. Rapid response times help us clamp down on issues before they spread. Every improvement in delivery method—smaller, clearer ampoules, more robust shipping containers, tighter batch tolerances—started with field feedback, not just regulatory paperwork.

    Improving Outcomes Through Manufacturing Focus

    Our teams don’t stop at meeting specifications. Batch after batch, subtle improvements add up: lower particulate counts, more robust packaging, faster handling for high-volume hospitals on tight schedules. We work closely with supply chain partners to pre-position product in areas with high seasonal demand or where emergencies strike more often.

    Efficient, safe, and rapid paracetamol injection depends on the equipment running well, yet our human commitment anchors the process. From line managers who catch a leaky cap before it goes in a box, to the operator recalibrating pH meters mid-batch, each person sees their impact reflected in recovery stories from hospital wards.

    Collaboration across departments helps bring fresh ideas. Our R&D team recently worked with clinical partners to investigate nanoparticles and controlled-release versions—not to replace the tried-and-true formula, but to expand options where traditional methods sometimes fall short.

    Education also plays a part. We offer on-site and virtual workshops for pharmacists and nurses handling our injectables, reviewing correct warming, dilution, and administration. Listening to those who draw, inspect, and inject our product sharpened our focus on clarity, color, and convenience.

    Looking Forward: What Comes Next?

    Innovation in injectable pain relief rarely happens overnight. As a manufacturing team, we focus on incremental gains—a one percent improvement in sterility, a five percent drop in out-of-spec waste, a reduction in transportation time thanks to improved route mapping. These changes keep our product at hospitals and clinics ready for the next challenge, whether it’s a pandemic surge, a local disaster, or routine surgery.

    Quality doesn’t stand still. Regulators raise standards, and we invest in upgraded clean rooms, higher-sensitivity monitoring, and new analytical testing. Where we see recurring field queries, we feed those back into our process. Paracetamol injection has already replaced less predictable oral or rectal forms in many emergency protocols, but we continue to invest in ease of use and absolute traceability.

    Today’s healthcare environment needs certainty more than ever. Our work with paracetamol injection delivers not just a product, but a chain of trust forged from factory floor to hospital bedside. We value the dialogue with healthcare workers and patients, knowing their feedback and scrutiny push us to do better. Every vial represents careful science, skilled hands, and a shared belief in relief and recovery.